A citation-based method for searching scientific literature


List of co-cited articles
460 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Zobair M Younossi, Aaron B Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer. Hepatology 2016
22

Mechanisms of NAFLD development and therapeutic strategies.
Scott L Friedman, Brent A Neuschwander-Tetri, Mary Rinella, Arun J Sanyal. Nat Med 2018
785
16

NAFLD: a multisystem disease.
Christopher D Byrne, Giovanni Targher. J Hepatol 2015
14

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Elena Buzzetti, Massimo Pinzani, Emmanuel A Tsochatzis. Metabolism 2016
903
13


Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.
Zobair Younossi, Quentin M Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Nat Rev Gastroenterol Hepatol 2018
8

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
Naga Chalasani, Zobair Younossi, Joel E Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A Harrison, Elizabeth M Brunt, Arun J Sanyal. Hepatology 2018
8

Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease.
Craig D Fisher, Andrew J Lickteig, Lisa M Augustine, James Ranger-Moore, Jonathan P Jackson, Stephen S Ferguson, Nathan J Cherrington. Drug Metab Dispos 2009
195
7

Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Zobair Younossi, Frank Tacke, Marco Arrese, Barjesh Chander Sharma, Ibrahim Mostafa, Elisabetta Bugianesi, Vincent Wai-Sun Wong, Yusuf Yilmaz, Jacob George, Jiangao Fan,[...]. Hepatology 2019
382
7


Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
David E Kleiner, Elizabeth M Brunt, Mark Van Natta, Cynthia Behling, Melissa J Contos, Oscar W Cummings, Linda D Ferrell, Yao-Chang Liu, Michael S Torbenson, Aynur Unalp-Arida,[...]. Hepatology 2005
6



Steatohepatitis: a tale of two "hits"?
C P Day, O F James. Gastroenterology 1998
6

Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.
Stergios A Polyzos, Jannis Kountouras, Christos S Mantzoros. Metabolism 2019
175
6

The global NAFLD epidemic.
Rohit Loomba, Arun J Sanyal. Nat Rev Gastroenterol Hepatol 2013
944
5

Non-alcoholic fatty liver disease: An expanded review.
Mark Benedict, Xuchen Zhang. World J Hepatol 2017
275
5

Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver.
Rohitash Jamwal, Suzanne M de la Monte, Ken Ogasawara, Sravani Adusumalli, Benjamin B Barlock, Fatemeh Akhlaghi. Mol Pharm 2018
35
14

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Konstantin Kazankov, Simon Mark Dahl Jørgensen, Karen Louise Thomsen, Holger Jon Møller, Hendrik Vilstrup, Jacob George, Detlef Schuppan, Henning Grønbæk. Nat Rev Gastroenterol Hepatol 2019
196
5

CYP3A Activity and Expression in Nonalcoholic Fatty Liver Disease.
Sarah J Woolsey, Sara E Mansell, Richard B Kim, Rommel G Tirona, Melanie D Beaton. Drug Metab Dispos 2015
61
8

Genetics and epigenetics of NAFLD and NASH: Clinical impact.
Mohammed Eslam, Luca Valenti, Stefano Romeo. J Hepatol 2018
283
5

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease.
Mario Masarone, Valerio Rosato, Marcello Dallio, Antonietta Gerarda Gravina, Andrea Aglitti, Carmelina Loguercio, Alessandro Federico, Marcello Persico. Oxid Med Cell Longev 2018
227
5

Non-alcoholic fatty liver disease.
Brent A Neuschwander-Tetri. BMC Med 2017
146
5

Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis.
Schohraya Spahis, Edgard Delvin, Jean-Michel Borys, Emile Levy. Antioxid Redox Signal 2017
172
5


Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
Geoffrey C Farrell, Claire Z Larter. Hepatology 2006
5

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
Zobair M Younossi, Pegah Golabi, Leyla de Avila, James Minhui Paik, Manirath Srishord, Natsu Fukui, Ying Qiu, Leah Burns, Arian Afendy, Fatema Nader. J Hepatol 2019
311
5

MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.
Mohammed Eslam, Arun J Sanyal, Jacob George. Gastroenterology 2020
449
5


Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.
Quentin M Anstee, Giovanni Targher, Christopher P Day. Nat Rev Gastroenterol Hepatol 2013
863
4

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease.
David Højland Ipsen, Jens Lykkesfeldt, Pernille Tveden-Nyborg. Cell Mol Life Sci 2018
248
4

Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments.
Hironori Kitade, Guanliang Chen, Yinhua Ni, Tsuguhito Ota. Nutrients 2017
158
4



Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.
Ariel E Feldstein, Ali Canbay, Paul Angulo, Makiko Taniai, Lawrence J Burgart, Keith D Lindor, Gregory J Gores. Gastroenterology 2003
725
4

Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease.
Giuseppe Paradies, Valeria Paradies, Francesca M Ruggiero, Giuseppe Petrosillo. World J Gastroenterol 2014
185
4

Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.
J Aubert, K Begriche, L Knockaert, M A Robin, B Fromenty. Clin Res Hepatol Gastroenterol 2011
164
4

Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.
Julie Massart, Karima Begriche, Caroline Moreau, Bernard Fromenty. J Clin Transl Res 2017
56
7

The natural history of nonalcoholic fatty liver disease: a population-based cohort study.
Leon A Adams, James F Lymp, Jenny St Sauver, Schuyler O Sanderson, Keith D Lindor, Ariel Feldstein, Paul Angulo. Gastroenterology 2005
4

Molecular pathways of nonalcoholic fatty liver disease development and progression.
Fernando Bessone, María Valeria Razori, Marcelo G Roma. Cell Mol Life Sci 2019
120
4

Nonalcoholic fatty liver disease.
Elizabeth M Brunt, Vincent W-S Wong, Valerio Nobili, Christopher P Day, Silvia Sookoian, Jacquelyn J Maher, Elisabetta Bugianesi, Claude B Sirlin, Brent A Neuschwander-Tetri, Mary E Rinella. Nat Rev Dis Primers 2015
300
4

Triglyceride Metabolism in the Liver.
Michele Alves-Bezerra, David E Cohen. Compr Physiol 2017
152
4

Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD.
A González-Rodríguez, R Mayoral, N Agra, M P Valdecantos, V Pardo, M E Miquilena-Colina, J Vargas-Castrillón, O Lo Iacono, M Corazzari, G M Fimia,[...]. Cell Death Dis 2014
291
4

Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents.
Leigh Goedeke, Jamie Bates, Daniel F Vatner, Rachel J Perry, Ting Wang, Ricardo Ramirez, Li Li, Matthew W Ellis, Dongyan Zhang, Kari E Wong,[...]. Hepatology 2018
85
4

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
Brandon J Perumpail, Muhammad Ali Khan, Eric R Yoo, George Cholankeril, Donghee Kim, Aijaz Ahmed. World J Gastroenterol 2017
236
4

Pathogenesis of Nonalcoholic Steatohepatitis.
Mariana Verdelho Machado, Anna Mae Diehl. Gastroenterology 2016
167
4

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.
Judith Aron-Wisnewsky, Chloé Vigliotti, Julia Witjes, Phuong Le, Adriaan G Holleboom, Joanne Verheij, Max Nieuwdorp, Karine Clément. Nat Rev Gastroenterol Hepatol 2020
103
4

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
Parambir S Dulai, Siddharth Singh, Janki Patel, Meera Soni, Larry J Prokop, Zobair Younossi, Giada Sebastiani, Mattias Ekstedt, Hannes Hagstrom, Patrik Nasr,[...]. Hepatology 2017
655
4

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis.
Simona Leoni, Francesco Tovoli, Lucia Napoli, Ilaria Serio, Silvia Ferri, Luigi Bolondi. World J Gastroenterol 2018
133
4

Current and future pharmacological therapies for NAFLD/NASH.
Yoshio Sumida, Masashi Yoneda. J Gastroenterol 2018
227
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.